Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia

dc.contributor.authorBraga, Antonio [UNESP]
dc.contributor.authorMaesta, Izildinha [UNESP]
dc.contributor.authorSoares, Renan Rocha [UNESP]
dc.contributor.authorElias, Kevin M.
dc.contributor.authorCustodio Domingues, Maria Aparecida [UNESP]
dc.contributor.authorBarbisan, Luis Fernando [UNESP]
dc.contributor.authorBerkowitz, Ross S.
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniversidade Federal Fluminense (UFF)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionBrigham & Womens Hosp
dc.date.accessioned2018-11-26T17:04:29Z
dc.date.available2018-11-26T17:04:29Z
dc.date.issued2016-09-01
dc.description.abstractBACKGROUND: Although 85% of patients with a complete hydatidiform mole achieve spontaneous remission after a few months, 15% of them will experience gestational trophoblastic neoplasia, which requires chemotherapy. To date, there is no biomarker to predict post-molar gestational trophoblastic neoplasia before the initiation of human chorionic gonadotropin surveillance. OBJECTIVE: The purpose of this study was to assess the relationship between the expression of apoptosis markers in the molar villous trophoblasts and the subsequent development of gestational trophoblastic neoplasia after the evacuation of a complete hydatidiform mole. STUDY DESIGN: This was a retrospective cohort study of patients with complete hydatidiform mole who were diagnosed, treated, and followed at the Center of Trophoblastic Diseases (Botucatu/Sao Paulo State and Rio de Janeiro/Rio de Janeiro State, Brazil) from 1995-2014. Patients were divided temporally into derivation (1995-2004) and validation (2005-2014) cohorts. Immunohistochemistry was used to examine tissue expression of the apoptosis inhibitor survivin or the proeapoptotic enzyme caspase-3. Survivin stains for cytoplasmic and nuclear expression were evaluated independently. Caspase-3 expression was measured as an apoptotic index of positive staining cells over negative staining cells multiplied by 100. Receiver operating characteristic curves were then constructed, and the area under the curve was calculated to test the performance characteristics of the staining to predict the subsequent development of gestational trophoblastic neoplasia. RESULTS: The final study population comprised 780 patients, with 390 patients in each temporal cohort: 590 patients entered spontaneous remission, and 190 patients experienced post-molar gestational trophoblastic neoplasia. Neither nuclear nor cytoplasmic survivin expression performed well as a predictor of subsequent gestational trophoblastic neoplasia. The caspase-3 apoptotic index was a strong risk factor for subsequent gestational trophoblastic neoplasia development. When the apoptotic index was < 4%, the risk of gestational trophoblastic neoplasia had an odds ratio of 35.55 (95% confidence interval, 14.02-90.14; P < .0001) in the derivation cohort and an odds ratio of 25.71 (95% confidence interval, 10.13-65.29; P <.0001) in the validation cohort. However, in both cohorts, the positive predictive value for gestational trophoblastic neoplasia of an apoptotic index < 4.0% was modest (49% in the derivation cohort and 41% in the validation cohort); the negative predictive value for gestational trophoblastic neoplasia of an apoptotic index >= 4.0% was high (97% in both cohorts). CONCLUSION: The subsequent development of gestational trophoblastic neoplasia after evacuation of complete hydatidiform mole is tied closely to the apoptotic index, which may be a useful biomarker for future prospective studies.en
dc.description.affiliationUniv Fed Rio de Janeiro, Matern Sch, Rio de Janeiro Trophoblast Dis Ctr, BR-21941 Rio De Janeiro, Brazil
dc.description.affiliationUniv Fed Fluminense, Antonio Pedro Univ Hosp, BR-24220000 Niteroi, RJ, Brazil
dc.description.affiliationSao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil
dc.description.affiliationSao Paulo State Univ, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil
dc.description.affiliationSao Paulo State Univ, Biosci Inst, Dept Morphol, Sao Paulo, Brazil
dc.description.affiliationBrigham & Womens Hosp, Dana Farber Canc Inst, Dept Obstet & Gynecol & Reprod Biol,Div Gynecol O, New England Trophoblast Dis Ctr,Donald P Goldstei, 75 Francis St, Boston, MA 02115 USA
dc.description.affiliationUnespSao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Biosci Inst, Dept Morphol, Sao Paulo, Brazil
dc.format.extent12
dc.identifierhttp://dx.doi.org/10.1016/j.ajog.2016.04.010
dc.identifier.citationAmerican Journal Of Obstetrics And Gynecology. New York: Mosby-elsevier, v. 215, n. 3, 12 p., 2016.
dc.identifier.doi10.1016/j.ajog.2016.04.010
dc.identifier.fileWOS:000382495100026.pdf
dc.identifier.issn0002-9378
dc.identifier.lattes3278528112652257
dc.identifier.urihttp://hdl.handle.net/11449/161876
dc.identifier.wosWOS:000382495100026
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofAmerican Journal Of Obstetrics And Gynecology
dc.relation.ispartofsjr2,700
dc.rights.accessRightsAcesso aberto
dc.sourceWeb of Science
dc.subjectapoptotic index
dc.subjectBrazil
dc.subjectcomplete hydatidiform mole
dc.subjectgestational trophoblastic neoplasia
dc.subjectreceiver operating characteristic
dc.subjectsurvivin
dc.titleApoptotic index for prediction of postmolar gestational trophoblastic neoplasiaen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
unesp.author.lattes3278528112652257[7]

Arquivos

Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000382495100026.pdf
Tamanho:
1.17 MB
Formato:
Adobe Portable Document Format
Descrição: